Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Intellia Therapeutics (NTLA US)
Watchlist
17
Analysis
Health Care
•
United States
Intellia Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the research and clinical development of gene editing therapies for patients with genetically-based diseases.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
03 Dec 2024 08:10
•
Issuer-paid
Biopharma Week in Review - December 2, 2024
The short holiday week saw another controversial name picked for NIH head, PSTX was acquired by RHHBY, AMGN underwhelmed with obesity data
Water Tower Research
Follow
139 Views
Share
bearish
•
Thematic (Sector/Industry)
•
26 Nov 2024 10:14
•
Issuer-paid
Biopharma Week in Review - November 25, 2024
Last week, the CDC and CMS picks aligned with President- elect Donald Trump’s agenda, while the FDA choice felt like a compromise.
Water Tower Research
Follow
142 Views
Share
bullish
•
Thematic (Sector/Industry)
•
02 Jul 2024 05:19
•
Issuer-paid
Biopharma Week in Review - July 1, 2024
We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A.
Water Tower Research
Follow
166 Views
Share
bearish
•
MSC Industrial Direct Co Inc
•
20 Oct 2021 20:20
Liquidity Risk Short Candidates: MSC Indus, Alphatec, Intellia Thera, PAR Tech
Liquidity Risk Short Candidates: MSC Indus, Alphatec, Intellia Thera, PAR Tech. All show tight cash positions, some show significant cash burn and...
Eric Fernandez, CFA
166 Views
Share
bullish
•
Thematic (Sector/Industry)
•
01 Jul 2021 09:35
•
Syndicated
Weekly Innovation Review (WIRE) #38
Headline Developments: We can now modify DNA inside of a human body (in vivo), thanks to some groundbreaking work announced this week
Granite Bay Capital
298 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x